We found that SGOL2 mRNA expression was upregulated in different tumors, including hepatocellular carcinoma, colorectal cancer, and breast cancer, in the Oncomine database (Fig. S1A). This evidence concerns the gene SGO2 and hepatocellular carcinoma.